Let’s use deep learning to do things that our brains are not tuned to do. Let’s assist pathology in that way, rather than trying to create a virtual pathologist.
Researchers have found that certain immune cells are not found in the blood. Some immune cells such as the macrophages are derived directly from the progenitor cells to mature in tissues such as the liver, lungs, and spleen. Other immune cells such as memory T cells develop from activated T cells which migrate to specific tissues where they reside for a long duration.
In 2015, we became the first completely digital pathology laboratory in the world and I believe pathology will follow the same process as radiology and will become entirely digital within a decade or so.
Findings of multi-site study highlight potential of technology in real-world practice PHILADELPHIA – October 5, 2021 – Proscia®, a leading provider of digital and computational pathology solutions, has released study results on new technology that leverages artificial intelligence (AI) to automatically detect melanoma, the deadliest form of skin cancer, with a high degree of accuracy. The findings illustrate [...]
Artificial intelligence (AI) involves the simulation by computer systems of the decision processes of the human brain, with the aim of mimicking certain actions such as problem-solving and learning. AI systems have been shown to be able to perform tasks that generally require human intelligence and in recent years, AI-based computational pathology has started to yield promising [...]
At Proscia, we talk a lot about AI-enabled digital pathology. We frequently pair these two concepts – digital pathology and AI – because we fundamentally believe that a focus on one is incomplete without the other.
We can try to understand the mechanisms of our diagnosis through large scale machine-learning projects, but a big wave is about to hit us, and it is one which will completely transform the field of digital pathology.
An international group of cancer researchers, led by the National Cancer Research Institute's (NCRI) Cellular Molecular Pathology Initiative (CMPath), has published guidance to address the variability in how pathology is planned and delivered in clinical trials.
NEW YORK--(BUSINESS WIRE)--Paige, the global leader in AI-based diagnostic software in pathology, today announced that the U.S. Food and Drug Administration (FDA) has granted de novo marketing authorization for Paige Prostate, a clinical-grade AI solution for prostate cancer detection. As a novel technology, Paige Prostate is the first AI-based pathology product to receive de novo approval from [...]
Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals who examine body tissues (pathologists) in the detection of areas that are suspicious for cancer as an adjunct (supplement) to the review of digitally-scanned slide images from prostate biopsies (tissue removed from the body). The software, called Paige Prostate, is the first [...]
